BIO-PATH HOLDINGS INC
For the period ended Dec 31, 2023. Filed Mar 7, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 7, 2024
BPTH$0.21-66.8%Stored close · as of Feb 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
(In thousands, except per share amounts)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Year Ended December 31, | ||||||
| · 2023 · 2022 | ||||||
| · · | ||||||
| Operating expenses · · | ||||||
| · · | ||||||
| Research and development | | $11,608 | | $9,165 | ||
| General and administrative | | 4,235 | | 4,736 | ||
| | | | | | ||
| Total operating expenses | | 15,843 | | 13,901 | ||
| | | | | | ||
| Net operating loss | | $(15,843) | | $(13,901) | ||
| | | | ||||
| Other income (loss) | | | ||||
| Change in fair value of warrant liability | | | (271) | | | — |
| Interest income | | 36 | | 33 | ||
| | | | | | ||
| Total other income (loss) | | (235) | | 33 | ||
| | | | ||||
| Net loss | | $(16,078) | | $(13,868) | ||
| | | | ||||
| Net loss per share, basic and diluted | | $(33.63) | | $(38.12) | ||
| | | | | | | |
| Basic and diluted weighted average number of common shares outstanding | | 478 | | 364 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.